Cytokinetics (CYTK) PT Lowered to $55 at JPMorgan
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $72.95 -1.35%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 4
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 4
Join SI Premium – FREE
JPMorgan analyst Tessa Romero lowered the price target on Cytokinetics (NASDAQ: CYTK) to $55.00 (from $64.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Reiterates Buy Rating on Cytokinetics (CYTK)
- Mama’s Creations (MAMA) PT Lowered to $22 at DA Davidson Following Q2 Beat
- Phreesia Inc. (PHR) PT Lowered to $13 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
